Christopher A. Gomez has experience in a wide range of legal matters – from representing plaintiffs and defendants, practicing in state and federal courts, and litigating matters from personal injury to mass torts to whistleblower litigation. And he has had success every step of the way.

Most recently, Gomez, a partner at the firm, teamed with attorneys from Cleveland and Pensacola in winning a $20 million Philadelphia jury verdict against Johnson & Johnson for injuries suffered by a New Jersey woman implanted with a vaginal mesh device. The award — $2.5 million in compensatory and $17.5 million in punitive damages – followed a three-week trial in April 2017 in which Gomez cross-examined a key liability and causation expert. (read stories)

Gomez also has been co-counsel in several trials against Janssen Pharmaceuticals over its failure to warn about the risks of the anti-psychotic drug Risperdal, namely its link to gynecomastia, or the growth of female breasts in boys and adolescent males. One highly publicized case produced a $2.5 million verdict in 2015 for a young autistic man afflicted with the ailment. (See stories)

Prior to joining Kline & Specter, Gomez worked at Sheller, PC, which pioneered Risperdal cases against Janssen, a Johnson & Johnson subsidiary. He was Sheller’s leader of case management, electronic discovery and litigation strategy. He also conducted pre-trial discovery and depositions.

An experienced trial lawyer, Gomez has represented clients in cases involving defective medical devices and general product liability claims, representing both individual clients and working on class action litigation. He has represented both plaintiffs and defendants including corporations, giving him broad perspective on litigation involving medical malpractice and other personal injury cases as well as mass torts. His work earned him recognition by the independent review group Pennsylvania Super Lawyers for 2013-2018. 

Before working at the Sheller firm, Gomez worked at The Miller Firm on mass tort pharmaceutical litigation, handling discovery and settlement negotiations involving a litany of other problematic drugs, among them Vioxx, Bextra, Zyprexa, Avandia and the diet drug Fen-Phen. He managed a client base of more than 5,000 at the firm, which has offices in Pennsylvania and Virginia. Gomez is licensed to practice in both states.

Gomez earned his bachelor’s degree at North Carolina State University and his law degree at Widener University School of Law, where he graduated in the top third of his class and was a member of the student government and the Moot Court Honor Society.

He is a member of the Pennsylvania and Virginia bar associations.